Meta-Analysis:
Comprehensive assessment of association between TLR4 gene polymorphisms and cancer risk: a systematic metaanalysis
PDF | Full Text | Supplementary Files | How to cite
Metrics: PDF 1932 views | Full Text 3249 views
Lu Ding1, Qifeng Jiang1, Guang Li1, Jia Shen1, Jiayin Du1, Xiaochen Lu1 and Xingliang Xiong1
1Department of Medical Informatics, Chongqing Medical University, Chongqing, 400016, China
Correspondence to:
Xingliang Xiong, email: [email protected]
Keywords: cancer risk, toll-like receptor, TLR4, SNP, meta-analysis
Received: July 18, 2017 Accepted: September 25, 2017 Published: October 06, 2017
ABSTRACT
Previous studies have explored the association between toll-like receptor 4 (TLR4) polymorphisms and risk of various cancers, but the results remained controversial. To obtain an assessment of the effect of TLR4 polymorphisms (rs4986790, rs4986791 and rs11536889) on cancer risk, fifty-five articles (containing 20107 cases and 28244 controls) were recruited for meta-analysis. Our result indicated that two Single Nucleotide Polymorphisms (SNP) in TLR4 were associated with decreased cancer risk for rs4986791: OR = 0.764, 95% CI: 0.652-0.894, P = 0.001 in allele model; OR = 0.769, 95%CI: 0.650-0.909, P = 0.002 in recessive model; OR = 0.505, 95% CI: 0.352-0.726, P = 0.000 in dominant model; for 11536889: OR = 0.927, 95% CI: 0.872–0.984, P = 0.013 in allele model; OR = 0.926, 95% CI: 0.862–0.944,P = 0.034 in recessive model. In terms of subgroup analyses sorted by ethnicity, only polymorphism of rs4986791 had a significant influence on decrease of cancer risk among both Caucasian and Asian populations. The findings suggested that TLR4 polymorphisms may serve as a genetic risk factor for cancers.